Montreal, Canada

Adi Eisenberg


Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 1978-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Adi Eisenberg: Innovator in Biological Agent Delivery Systems

Introduction

Adi Eisenberg is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biological agent delivery systems, holding a total of four patents. His work focuses on enhancing the efficacy of therapeutic and diagnostic agents through innovative compositions.

Latest Patents

Eisenberg's latest patents include a composition for the delivery of biological agents and methods for their preparation. This composition facilitates the delivery of biological agents by utilizing a supramolecular complex. The complex consists of a block copolymer with both nonionic, water-soluble segments and polyionic segments, along with charged surfactants that possess hydrophobic groups. The interaction between the opposite charges of the surfactant and the polyionic segment of the block copolymer enhances the binding of the constituents. Additionally, the therapeutic or diagnostic agent may be an ionic substance, ensuring that the net charge remains balanced.

Career Highlights

Throughout his career, Adi Eisenberg has worked with prestigious institutions such as McGill University and the University of Nebraska Board of Regents. His research has focused on developing advanced methods for the preparation and delivery of biological agents, contributing to the advancement of medical technologies.

Collaborations

Eisenberg has collaborated with notable individuals in his field, including Alexander Victorovich Kabanov and Victor A. Kabanov. These collaborations have further enriched his research and innovation efforts.

Conclusion

Adi Eisenberg's work in the field of biological agent delivery systems exemplifies the impact of innovative thinking in medical research. His patents and collaborations highlight his commitment to advancing therapeutic technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…